)
)
Vyant Bio Investor Relations Material
Latest events
Q3 2022
Vyant Bio
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Vyant Bio Inc
Access all reports
Vyant Bio, Inc. operates as a biotechnology drug discovery company. The company discovers, develops, and commercializes antimicrobial drugs to treat acute respiratory tract infections, including pneumonia and influenza.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
VYNT
Country
🇺🇸 United States